Zobrazeno 1 - 10
of 344
pro vyhledávání: '"M. Rodriguez Lopez"'
Publikováno v:
European Psychiatry, Vol 67, Pp S540-S541 (2024)
Introduction Major depressive disorder is a common psychiatric condition affecting around 264 million people worldwide (WHO: Depression Fact Sheet. [Apr;2021]). Despite pharmacological advances, many patients still do not respond to antidepressant tr
Externí odkaz:
https://doaj.org/article/1bce58fe7d9d4cbaabf8736bfefbfb5a
Autor:
Tilo Winkler, Puja Kohli, Vanessa J. Kelly, Ekaterina G. Kehl, Alison S. Witkin, Josanna M. Rodriguez-Lopez, Kathryn A. Hibbert, Mamary T. Kone, David M. Systrom, Aaron B. Waxman, Jose G. Venegas, Richard N. Channick, R. Scott Harris
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-16 (2022)
Abstract Background Without aggressive treatment, pulmonary arterial hypertension (PAH) has a 5-year mortality of approximately 40%. A patient’s response to vasodilators at diagnosis impacts the therapeutic options and prognosis. We hypothesized th
Externí odkaz:
https://doaj.org/article/b72092f0ebae45b79c5c838832f9ffbc
Publikováno v:
BMC Bioinformatics, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background The recent advancements in high-throughput sequencing have resulted in the availability of annotated genomes, as well as of multi-omics data for many living organisms. This has increased the need for graphic tools that allow the c
Externí odkaz:
https://doaj.org/article/8e724816b8524b56ab7048d72324eb01
Autor:
Irun Bhan, Esperance A. Schaefer, William R. Bradley, Josanna M. Rodriguez-Lopez, Jerome C. Crowley, Bailey Hutchison
Publikováno v:
New England Journal of Medicine. 388:544-554
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::141ede478b0cdb02027a2c8e11d35ad3
https://doi.org/10.1056/nejmcpc2201249
https://doi.org/10.1056/nejmcpc2201249
Autor:
Smita Sihag, Bao Le, Alison S. Witkin, Josanna M. Rodriguez-Lopez, Mauricio A. Villavicencio, Gus J. Vlahakes, Richard N. Channick, Cameron D. Wright
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 12, Iss 1, Pp 1-6 (2017)
Abstract Background Pulmonary thromboendarterectomy (PTE) is an effective treatment for chronic thromboembolic pulmonary hypertension (CTEPH), but is a technically challenging operation for cardiothoracic surgeons. Starting a new program allows an op
Externí odkaz:
https://doaj.org/article/81dbb5cc662d46b48b850d98d03675d6
Publikováno v:
Epigenomes, Vol 5, Iss 4, p 24 (2021)
In contrast to animals, adult organs in plants are not formed during embryogenesis but generated from meristematic cells as plants advance through development. Plant development involves a succession of different phenotypic stages and the transition
Externí odkaz:
https://doaj.org/article/b0d61c2a751b46a7bc882eb478d23d09
Autor:
Belinda Rivera-Lebron MD, MS, FCCP, Michael McDaniel MD, FACC, FSCAI, Kamran Ahrar MD, MBA, Abdulah Alrifai MD, David M. Dudzinski MD, Christina Fanola MD, MSC, Danielle Blais PharmD, BCPS-AQ Cardiology, David Janicke MD, PhD, Roman Melamed MD, FCCP, Kerry Mohrien PharmD, BCPS, Elizabeth Rozycki PharmD, BCPS, Charles B. Ross MD, FACS, Andrew J. Klein MD, Parth Rali MD, Nicholas R. Teman MD, Leoara Yarboro MD, Eugene Ichinose MD, Aditya M. Sharma MBBS, Jason A. Bartos MD, PhD, Mahir Elder MD, FACC, FSCAI, FCCP, Brent Keeling MD, Harold Palevsky MD, Soophia Naydenov MD, FCCP, Parijat Sen MBBS, MD, Nancy Amoroso MD, Josanna M. Rodriguez-Lopez MD, George A. Davis Pharm D, Rachel Rosovsky MD, Kenneth Rosenfield MD, MHCDS, FACC, FSCAI, Christopher Kabrhel MD, MPH, James Horowitz MD, Jay S. Giri MD, MPH, Victor Tapson MD, FCCP, FRCP, Richard Channick MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity and mortality. There have been many advances in the field of PE in the last few years, requiring a careful assessment of their impact on patient care. However, v
Externí odkaz:
https://doaj.org/article/f878eb54aa9b4bd79415ba74637761d2
Autor:
Nicola G. Wallis, Neil T. Thompson, John Lyons, Patrick Schöffski, Jonathan A. Fletcher, Mark Mayeda, Jennifer G. Morgan, Rachel Donsky, Meijun Zhu, Agnieszka Wozniak, Ana M. Rodriguez-Lopez, Jayne E. Curry, Thomas Van Looy, Tomoko Smyth
PDF file, 289KB, Western immunoblots and their densitometric analyses showing the pharmacodynamic response of GIST430 xenograft to 22 days of AT13387, imatinib or combination treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd1cebda49e8d94a1721204465a08cb
https://doi.org/10.1158/1535-7163.22498803.v1
https://doi.org/10.1158/1535-7163.22498803.v1
Autor:
Nicola G. Wallis, Neil T. Thompson, John Lyons, Patrick Schöffski, Jonathan A. Fletcher, Mark Mayeda, Jennifer G. Morgan, Rachel Donsky, Meijun Zhu, Agnieszka Wozniak, Ana M. Rodriguez-Lopez, Jayne E. Curry, Thomas Van Looy, Tomoko Smyth
PDF file, 56KB, Graphs showing the typical dose response of GIST882, GIST430 and GIST48 cell lines to AT13387 and imatinib.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85068f99b5a98f7424ed9d866e7ecdb7
https://doi.org/10.1158/1535-7163.22498806
https://doi.org/10.1158/1535-7163.22498806
Autor:
Nicola G. Wallis, Neil T. Thompson, John Lyons, Patrick Schöffski, Jonathan A. Fletcher, Mark Mayeda, Jennifer G. Morgan, Rachel Donsky, Meijun Zhu, Agnieszka Wozniak, Ana M. Rodriguez-Lopez, Jayne E. Curry, Thomas Van Looy, Tomoko Smyth
The majority of gastrointestinal stromal tumors (GIST) are characterized by activating mutations of KIT, an HSP90 client protein. Further secondary resistance mutations within KIT limit clinical responses to tyrosine kinase inhibitors, such as imatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c79bfd68c90607a7e4450a9897a31f
https://doi.org/10.1158/1535-7163.c.6535971
https://doi.org/10.1158/1535-7163.c.6535971